BACIL PHARMA LTD.

Scale -

Ebitda is 0.99 Rs Cr; Annual Growth is 141 %; Continuous Growth over 3 years
PBT is 0.07 Rs Cr; Annual Growth is 141 %; in Bottom Quartile
PAT is 1.56 Rs Cr; Annual Growth is 290 %; Continuous Growth over 3 years

Revenue is 0 Rs Cr; in Bottom Quartile
Quarterly Profit is -0.02 Rs Cr; in Bottom Quartile

Profitability -

PBDIT Margin is 0 %; in Bottom Quartile

Return -

ROCE is 3.99 %; Annual Growth is 149 %; Continuous Growth over 3 years
ROA is 5.67 %; Annual Growth is 261 %; Continuous Growth over 3 years
ROE is 6.26 %; Annual Growth is 296 %; Continuous Growth over 3 years

Asset Turnover is 0 %; in Bottom Quartile

Efficiency -

Operating cash flow is 0.71 Rs Cr; Annual Growth is 77 %; Continuous Growth over 3 years

Current Ratio is 0.68; Annual Decline is -96 %; in Bottom Quartile; 5 Year CAGR is -50 %
Quick Ratio is 0.68; Annual Decline is -96 %; in Bottom Quartile; 5 Year CAGR is -50 %
Inventory Turnover Ratio is 0; in Bottom Quartile

Solvancy -

Debt/Equity is 0; Annual Decline is -100 %; Continuous Decline over 3 years; in Bottom Quartile
Total Debt is 0 Rs Cr; Annual Decline is -100 %; in Bottom Quartile
Long term Debt is 0 Rs Cr; in Bottom Quartile

Contingent Liabilities is 0 Rs Cr; in Top Quartile

Quality -

Operating cashflow/ebitda is 72 %; Annual Decline is -26 %
Operating cashflow/PAT is 46 %; Annual Decline is -54 %; 5 Year CAGR is -19 %
Other Expenses/Total Expenses is 80 %; Annual Growth is 82 %; in Top Quartile
Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: